Aida Lopez

Vigo, GA, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV.

Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV.

Journal: Infectious diseases and therapy
Published: May 29, 2026

IL-18 and MIG increase one year after transition to dolutegravir-based dual therapy despite sustained viral suppression.

IL-18 and MIG increase one year after transition to dolutegravir-based dual therapy despite sustained viral suppression.

Journal: Frontiers in immunology
Published: January 10, 2026

Elevated Plasma GDF-15 Levels Are Associated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV.

Elevated Plasma GDF-15 Levels Are Associated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV.

Journal: Infectious diseases and therapy
Published: November 12, 2025

Artificial intelligence-based identification of key risk factors for long COVID from early clinical data.

Artificial intelligence-based identification of key risk factors for long COVID from early clinical data.

Journal: Journal of infection and public health
Published: March 18, 2025

High prevalence of polypharmacy and nervous system medications in people with HIV: a cross-sectional analysis.

High prevalence of polypharmacy and nervous system medications in people with HIV: a cross-sectional analysis.

Journal: Scientific reports
Published: January 28, 2025

Effectiveness and safety of pembrolizumab as first-line treatment for non-small cell lung cancer in real clinical practice.

Effectiveness and safety of pembrolizumab as first-line treatment for non-small cell lung cancer in real clinical practice.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 23, 2024

SARS-CoV-2 Viral Load and Cytokine Dynamics Profile as Early Signatures of Long COVID Condition in Hospitalized Individuals.

SARS-CoV-2 Viral Load and Cytokine Dynamics Profile as Early Signatures of Long COVID Condition in Hospitalized Individuals.

Journal: Influenza and other respiratory viruses
Published: July 09, 2024

Real-world evidence of sorafenib for the treatment of hepatocellular carcinoma: A single-center study.

Real-world evidence of sorafenib for the treatment of hepatocellular carcinoma: A single-center study.

Journal: Journal of cancer research and therapeutics
Published: October 03, 2023

Regorafenib and trifluridine/tipiracil in real clinical practice.

Regorafenib and trifluridine/tipiracil in real clinical practice.

Journal: Journal of cancer research and therapeutics
Published: December 13, 2022

Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC.

Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC.

Journal: Cancers
Published: April 29, 2022

Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion.

Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 14, 2021

Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.

Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.

Journal: Journal of clinical pharmacy and therapeutics
Published: November 17, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026